AML, Childhood

Oncology·MeSH: Leukemia, Myeloid, Acute

19 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Haematopoietic growth factor	Structure Therapeutics Inc. (GPCR)

Phase 2(8)

Drug	Company
Fludarabine	Structure Therapeutics Inc. (GPCR)
Fludarabine phosphate	Structure Therapeutics Inc. (GPCR)
Haploidentical donor bone marrow transplant	Structure Therapeutics Inc. (GPCR)
Hematopoietic stem cell transplant	Structure Therapeutics Inc. (GPCR)
Melphalan	Structure Therapeutics Inc. (GPCR)
Plerixafor	Structure Therapeutics Inc. (GPCR)
Rabbit Anti thymocyte globulin	Structure Therapeutics Inc. (GPCR)
Thiotepa	Structure Therapeutics Inc. (GPCR)

Phase 1(8)

Drug	Company
Busulfan	Structure Therapeutics Inc. (GPCR)
IL-2	ENANTA PHARMACEUTICALS INC (ENTA)
IL-2	Structure Therapeutics Inc. (GPCR)
memory-like natural killer cells	Structure Therapeutics Inc. (GPCR)
mRNA plus Lysate-loaded Dendritic Cell Vaccine	Structure Therapeutics Inc. (GPCR)
PEGYLATED-INTERFERON ALPHA-2A	Structure Therapeutics Inc. (GPCR)
Peripheral Blood Stem Cell Infusion	Structure Therapeutics Inc. (GPCR)
Thiotepa	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(2)

Drug	Company
Granulocyte Colony-Stimulating Factor	Structure Therapeutics Inc. (GPCR)
Recombinant Granulocyte Colony-Stimulating Factor	Structure Therapeutics Inc. (GPCR)

BioSniper tracks 19 drugs in development for AML, Childhood across 2 companies.

There are 1 clinical trial targeting AML, Childhood tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.